Related Experiment Videos
Platelet dysfunction in the neonate with essential fatty acid deficiency
The Journal of Pediatrics
|March 1, 1977
Summary
Essential fatty acid (EFA) deficiency in premature infants receiving parenteral nutrition impairs platelet aggregation and increases hemorrhage risk. Supplementation improved platelet function, suggesting a causal link.
Area of Science:
- Biochemistry
- Neonatal Medicine
- Hematology
Background:
- Parenteral nutrition (PN) in premature infants can lead to essential fatty acid (EFA) deficiency.
- EFA deficiency impacts various physiological processes, including hemostasis.
Purpose of the Study:
- To investigate the effect of EFA deficiency on platelet aggregation in sick premature newborns.
- To explore the relationship between EFA deficiency, platelet dysfunction, and clinical hemorrhage.
Main Methods:
- Assessed platelet aggregation in response to adenosine diphosphate (ADP) in five EFA-deficient premature infants on fat-free PN.
- Diagnosed EFA deficiency via plasma lipid fatty acid analysis.
- Compared platelet function to control low-birth-weight infants fed orally.
Main Results:
- EFA-deficient infants exhibited significantly impaired platelet aggregation (e.g., 18.1% vs. 43.4% at 2.5 muM ADP).
- Platelets from deficient infants showed marked disaggregation.
- Four of five EFA-deficient infants experienced clinical hemorrhage.
- Platelet function normalized upon recovery from EFA deficiency.
Conclusions:
- EFA deficiency, specifically of arachidonic acid, is strongly correlated with impaired platelet aggregation mediated by thromboxane A2.
- The findings support a hypothesis that EFA deficiency causally contributes to platelet dysfunction and bleeding in premature infants.
- This highlights the importance of adequate EFA provision in neonatal PN.